Medical School News and Research

RSS

A 'home far away from home' for medical students

When Sebastian Leder, a medical student from the University of Vienna in Austria, came to the Wake Forest University School of Medicine to complete his clinical education, he found not the usual student apartment but an inviting house waiting for him.

24 Nov 2009

Doctor shortage issue heats up with reform efforts

The Miami Herald reports: "Some parts of the country already lack an ample supply of general internists, pediatricians and family physicians, forcing patients to drive further or wait longer for care. If a comprehensive health reform bill passes and extends coverage to millions of uninsured Americans, many are asking if there will be enough primary-care doctors to handle the increased demand for medical services."

23 Nov 2009

Gene deletion can increase common complication of bone marrow transplants

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.

23 Nov 2009

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public. However, an analysis from Children's Hospital Boston, based on patients seen in its emergency department (ED) during several recent flu seasons, shows that another virus - respiratory syncytial virus (RSV) - takes a substantially greater disease toll among young children than does seasonal flu.

23 Nov 2009

Emotionally abused children may face accelerated cellular aging as adults

Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University.

21 Nov 2009

Whole genome analysis identifies 43 genetic loci contributing to lipoprotein metabolism

Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.

21 Nov 2009

Groundbreaking discovery provides fundamental insights into neurological disorders

Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical School and neurologist at the Massachusetts General Hospital in Boston, on Thursday, November 19, presented his laboratory's research on the new field of study called "Connectivity" at the launch of the MINDlink Foundation.

21 Nov 2009

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.

20 Nov 2009

Increased computerization in U.S. hospitals hasn't made them cheaper or more efficient, say researchers

The increased computerization in U.S. hospitals hasn't made them cheaper or more efficient, Harvard researchers say, although it may have modestly improved the quality of care for heart attacks.

20 Nov 2009

Pediatric immunologist receives prestigious annual award from American Philosophical Society

A pediatric immunologist at The Children's Hospital of Philadelphia has received a prestigious annual award from the American Philosophical Society, an organization founded in 1743 by Benjamin Franklin. Jordan S. Orange, M.D., Ph.D., received the Society's Judson Daland Prize on Nov. 13 for his contributions to research and treatment of inherited immune deficiency diseases.

20 Nov 2009

GERD is an immune-mediated injury and not the result of acid burn, says new study

Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study.

20 Nov 2009

H1N1: Bridging the knowledge gap

A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. Infectious diseases specialist Leonard Mermel, DO, medical director of infection control for Rhode Island Hospital, looks at the ongoing debate in light of the H1N1 pandemic, what past research tells us about the spread of influenza, and what is missing in the debate. His commentary is currently available in an online first edition.

20 Nov 2009

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.

19 Nov 2009

Treatment of iron deficiency can improve symptoms and quality of life in CHF patients

Intravenous (I.V.) iron treatment with ferric carboxymaltose to reverse iron deficiency can significantly improve symptoms, exercise tolerance and quality of life for chronic heart failure (CHF) patients, researchers said in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

19 Nov 2009

Possible new approach to slow the progression of cognitive decline in Down's syndrome

A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome.

19 Nov 2009

Halifax researcher wins Prix Galien Research Award

Dr. Donald Weaver, a Halifax researcher with unmatched credentials, received the Prix Galien Research Award at a ceremony in Ottawa last night. Known as the Nobel Prize of pharmaceutical research, this award is the highest distinction worldwide for biopharmaceutical work, and the most prestigious in the field of Canadian pharmaceutical research and innovation.

19 Nov 2009

People with egg allergy can have H1N1 flu vaccine in graded doses

As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation.

19 Nov 2009

Fully integrated human genome sequencing and data processing service launched

Knome, Inc., a recognized pioneer in the personal genomics field, today announced the launch of KnomeDISCOVERY, the first fully integrated human genome sequencing and data processing service for researchers. The new offering meets rapidly emerging demand from biomedical researchers for a one-stop service that bundles affordable, research-tailored access to a broad range of next-generation sequencing platforms with discovery-supportive data management and analysis.

18 Nov 2009

A selection of today's opinions and editorials

Rather than work with us to find a true compromise, members who support abortion rights ignored our concerns (Rep. Bart Stupak, D-Mich., 11/18).

18 Nov 2009

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.

18 Nov 2009

Medical School News and Research

A 'home far away from home' for medical students

Doctor shortage issue heats up with reform efforts

Gene deletion can increase common complication of bone marrow transplants

RSV found to cause more emergency department visits and hospitalizations than seasonal flu

Emotionally abused children may face accelerated cellular aging as adults

Whole genome analysis identifies 43 genetic loci contributing to lipoprotein metabolism

Groundbreaking discovery provides fundamental insights into neurological disorders

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

Increased computerization in U.S. hospitals hasn't made them cheaper or more efficient, say researchers

Pediatric immunologist receives prestigious annual award from American Philosophical Society

GERD is an immune-mediated injury and not the result of acid burn, says new study

H1N1: Bridging the knowledge gap

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

Treatment of iron deficiency can improve symptoms and quality of life in CHF patients

Possible new approach to slow the progression of cognitive decline in Down's syndrome

Halifax researcher wins Prix Galien Research Award

People with egg allergy can have H1N1 flu vaccine in graded doses

Fully integrated human genome sequencing and data processing service launched

A selection of today's opinions and editorials

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News